Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
Clinical trial NCT02544308 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02544308
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2026-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.